Brainstorm Cell Therapeutics Files 8-K

Ticker: BCLI · Form: 8-K · Filed: May 19, 2025 · CIK: 1137883

Brainstorm Cell Therapeutics Inc. 8-K Filing Summary
FieldDetail
CompanyBrainstorm Cell Therapeutics Inc. (BCLI)
Form Type8-K
Filed DateMay 19, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, 8-k

TL;DR

Brainstorm Cell Therapeutics filed an 8-K on 5/19/25, likely containing updates for investors.

AI Summary

On May 19, 2025, Brainstorm Cell Therapeutics Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." No specific financial figures or significant business events were detailed in the provided excerpt.

Why It Matters

This 8-K filing indicates that Brainstorm Cell Therapeutics Inc. is providing updates to the SEC, which could contain important information for investors regarding the company's financial status or operational developments.

Risk Assessment

Risk Level: low — The provided excerpt is a standard SEC filing notification and does not contain specific financial or operational details that would indicate immediate risk.

Key Players & Entities

  • Brainstorm Cell Therapeutics Inc. (company) — Registrant
  • May 19, 2025 (date) — Date of earliest event reported

FAQ

What specific "Other Events" are reported in this 8-K filing?

The provided excerpt does not detail the specific "Other Events" covered in the 8-K filing.

What "Financial Statements and Exhibits" are included with this filing?

The excerpt states that "Financial Statements and Exhibits" are part of the filing, but does not list their specific contents.

What is the primary purpose of this 8-K filing for Brainstorm Cell Therapeutics Inc.?

The filing is a Current Report filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, indicating it reports significant events or information.

When was Brainstorm Cell Therapeutics Inc. incorporated and in which jurisdiction?

Brainstorm Cell Therapeutics Inc. was incorporated in Delaware.

What is the IRS Employer Identification Number for Brainstorm Cell Therapeutics Inc.?

The IRS Employer Identification Number for Brainstorm Cell Therapeutics Inc. is 20-7273918.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 19, 2025 regarding BRAINSTORM CELL THERAPEUTICS INC. (BCLI).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.